Related Products

Summary Of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid-Fine & Speciality Chemicals

Chemical Name

5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

CAS No.

17687-24-0, 60779-49-9

Synonyms

2,4-Dihydroxy-5-Nitro-6-Carboxypyrimidine; 2,6-Dihydroxy-5-Nitropyrimidine-4-Carboxylic Acid; 5-Nitro-2,4-Dioxo-1H-Pyrimidine-6-Carboxylic Acid; 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid; 5-Nitroorotic Acid

Molecular Formula

C5H3N3O6

Molecular Weight

201.09

Detailed Summary of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API-Small Molecules

Chemxpert provides a consolidated intelligence snapshot for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API-Small Molecules, covering its technical profile, commercial footprint, global 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid supplier, 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid buyer and 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid manufacturer dynamics, and regulatory presence across key pharmaceutical markets.

Innovator and developer details, where available, are reflected based on verified disclosures within Chemxpert database.

Technical & Application Intelligence for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid technical & application intelligence includes information on the industry and end-use applications, helping users understand its role across different formulation and therapeutic contexts. The data also covers routes of synthesis and manufacturing technologies, offering visibility into production methods, process variability, and technical complexity.

In addition, the mechanism of action describes how an API ingredient produces its therapeutic effect at the molecular or biological level in the body. This data supports scientific understanding, formulation development, and regulatory evaluation of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid.

Chemxpert tracks the technical landscape of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid across its manufacturing and application ecosystem.

Commercial & Market Indicators for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

Commercial & Market Indicators reflects the sales performance of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid–based products across key pharmaceutical markets, including regulated regions such as the United States and the United Kingdom where available. It helps users understand regional demand trends, market maturity, and commercial presence of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid in major drug markets.

  • 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid global market size is tracked in both volume (metric tonne) and value (USD)
  • Pricing intelligence includes average 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API price benchmarks (USD/kg) derived from multiple verified sources
  • Regional 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API sales performance including markets such as the US and UK is monitored where data is available

Global Supplier Landscape for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid global supplier landscape provides intelligence on the API global supply ecosystem, helping users identify manufacturers, assess supply scale, and evaluate regulatory readiness.

  • 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API Suppliers – Companies involved in the manufacturing or commercial supply of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid
  • Supplying Volume – Indicator of quantity supplied used to assess production scale and capacity
  • Supplier Country Presence – Geographic distribution across countries
  • Supplier Regulatory Certifications – GMP, FDA and other approvals held by facilities
  • 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API Verified Supplier Contact Information – Validated business contact details

Together, this supplier intelligence supports supplier discovery, qualification, diversification planning, and supply risk assessment. This dataset supports supplier qualification, diversification planning, and sourcing risk mitigation.

Buyer & Demand Intelligence for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

On the demand side, 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API buyer supplier data intelligence tracks global procurement activities.

  • Total identified buyers across the globe
  • Total buying volume in metric tonne
  • Buyer presence across countries
  • Total number of certified buyers
  • Verified 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API buyer contact records

This intelligence enables demand mapping, partner discovery, and market entry evaluation.

Get the detailed insight about 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid technical, commercial, supplier and buyer –Click here

Regulatory Filings & Market Authorization for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid regulatory filings & market authorization provide a comprehensive view of approval status across global pharmaceutical markets.

  • US Drug Master File (US-DMF)
  • FDA National Drug Code (NDC)
  • Certificate of Suitability (CEP / COS)
  • EU API Registration
  • UK-MHRA Registration
  • REACH Registration
  • Written Confirmation

Asia-Pacific & Other Regional Filings

  • Japan Drug Master File (J-DMF)
  • Korea Drug Master File (K-DMF)
  • India Import Licence
  • China API Registration
  • Other regional registrations (Middle East, Africa, Latin America)

Finished Dosage Form (FDF) Market Authorization

  • North America
  • Europe
  • Oceania
  • Africa
  • Asia
  • South America

Geographic Distribution of 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid Counterparties

  • North America
  • Europe (Northern, Western, Southern, Eastern)
  • Asia
  • Africa
  • Middle East
  • South America
  • Oceania

Country-level counts are dynamically populated to reflect real-time database coverage.

Get the detailed insight about 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid Regulatory, Commercial and Geographic Distribution –Click here

Clinical, Patent & Compliance Intelligence for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

Clinical Trial Activity

Tracks ongoing and completed trials across the US, Europe, Asia-Pacific and India.

Patent & Exclusivity Landscape

  • Patent expiry
  • Market exclusivity
  • SPC extensions
  • Paragraph IV filings
  • Patent disputes & data protection

Certifications & Accreditations

  • US FDA
  • EU GMP
  • PMDA (Japan)
  • ANVISA (Brazil)
  • CDSCO, WHO-GMP, PIC/S

Regulatory Warnings & Compliance Signals

  • FDA warnings and recalls
  • Form 483 observations
  • Site inspection records
  • Country bans, price controls and essential medicine listings

Get detailed insight on 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid Clinical, Patent & Compliance –Click here

Biosimilar & Agrochemical Regulatory Status for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid

Chemxpert tracks biosimilar and agrochemical regulatory activity related to 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid across global markets. A regulatory dashboard reflects filing and approval status in the US, Europe, Japan, India, China and other countries.

Get detailed Biosimilar & Agrochemical Regulatory Insight – Click here

Why Use Chemxpert for 5-Nitro-2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid API Intelligence?

Chemxpert combines supplier data, regulatory depth, commercial indicators, US DMF and compliance intelligence into a single continuously updated platform — helping pharmaceutical companies, buyers and regulators make faster and better-informed decisions.